Heart artery study tests smarter imaging to prevent attacks

NCT ID NCT01881555

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding a special pressure wire measurement (FFR) to standard angiography helps doctors decide the best treatment for people with multiple blocked heart arteries. Over 900 patients were randomly assigned to get either angiography alone or angiography plus FFR to guide their care. The goal was to see if the FFR-guided approach reduces major heart problems like death, heart attack, or the need for more procedures within one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

invasive coronary angiography with or without fractional flow reserve (FFR) measurement

What this could lead to

If successful, this could show that adding FFR testing to angiography helps doctors choose better treatments, reducing heart attacks and deaths in people with multiple blocked arteries.

What could go wrong

This trial is completed, but the results may not apply to all patients or settings. FFR testing adds time and cost, and the benefit may be small or limited to certain subgroups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STABLE ANGINA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome Angina, Stable coronary artery disorder intermediate coronary syndrome ST-elevation myocardial infarction vascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HOSPICES

    Lyon, 69002, France